1 |
GRIFFITHS C E M, ARMSTRONG A W, GUDJONSSON J E, et al. Psoriasis[J]. Lancet, 2021, 397(10281): 1301-1315.
|
2 |
TASHIRO T, SAWADA Y. Psoriasis and systemic inflammatory disorders[J]. Int J Mol Sci, 2022, 23(8): 4457.
|
3 |
THIRUMAL D, SINDHU R K, GOYAL S, et al. Pathology and treatment of psoriasis using nanoformulations[J]. Biomedicines, 2023, 11(6): 1589.
|
4 |
XIE W H, HUANG H, DENG X R, et al. Modifiable lifestyle and environmental factors associated with onset of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational studies[J]. J Am Acad Dermatol, 2021, 84(3): 701-711.
|
5 |
NORDEN A, REKHTMAN S, STRUNK A, et al. Risk of psoriasis according to body mass index: a retrospective cohort analysis[J]. J Am Acad Dermatol, 2022, 86(5): 1020-1026.
|
6 |
PIETRZAK A, CHABROS P, GRYWALSKA E, et al. Serum lipid metabolism in psoriasis and psoriatic arthritis: an update[J]. Arch Med Sci, 2019, 15(2): 369-375.
|
7 |
CARUSO A, GELSOMINO L, PANZA S, et al. Leptin: a heavyweight player in obesity-related cancers[J]. Biomolecules, 2023, 13(7): 1084.
|
8 |
YAN H X, YU B, TIAN J L, et al. Serum leptin and adiponectin: indicators of cardiovascular disease secondary to psoriasis[J]. Indian J Dermatol, 2022, 67(2): 109-114.
|
9 |
CERMAN A A, BOZKURT S, SAV A, et al. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis[J]. Br J Dermatol, 2008, 159(4): 820-826.
|
10 |
YANG X L, WANG H L. miRNAs flowing up and down: the concerto of psoriasis[J]. Front Med, 2021, 8: 646796.
|
11 |
CHEN C, DENG Y, HU X G, et al. MiR-128-3p regulates 3T3-L1 adipogenesis and lipolysis by targeting Pparg and Sertad2[J]. J Physiol Biochem, 2018, 74(3): 381-393.
|
12 |
KIM S. LncRNA-miRNA-mRNA regulatory networks in skin aging and therapeutic potentials[J]. Front Physiol, 2023, 14: 1303151.
|
13 |
CHEN S S, WANG J L, ZHANG K L, et al. LncRNA Neat1 targets NonO and miR-128-3p to promote antigen-specific Th17 cell responses and autoimmune inflammation[J]. Cell Death Dis, 2023, 14(9): 610.
|
14 |
ORTIZ-LOPEZ L I, CHOUDHARY V, BOLLAG W B. Updated perspectives on keratinocytes and psoriasis: keratinocytes are more than innocent bystanders[J]. Psoriasis, 2022, 12: 73-87.
|
15 |
WANG F, GAO Y T, YUAN Y T, et al. MicroRNA-31 can positively regulate the proliferation, differentiation and migration of keratinocytes[J]. Biomed Hub, 2020, 5(2): 93-104.
|
16 |
MOSTAFA S A, MOHAMMAD M H S, NEGM W A, et al. Circulating microRNA203 and its target genes' role in psoriasis pathogenesis[J]. Front Med, 2022, 9: 988962.
|
17 |
JIN Z, HUANG Q S, PENG J, et al. MiR-125a-3p alleviates hyperproliferation of keratinocytes and psoriasis-like inflammation by targeting TLR4/NF-κB pathway[J]. Postepy Dermatol Alergol, 2023, 40(3): 447-461.
|
18 |
SŁUCZANOWSKA-GŁABOWSKA S, STANISZEWSKA M, MARCHLEWICZ M, et al. Adiponectin, leptin and resistin in patients with psoriasis[J]. J Clin Med, 2023, 12(2): 663.
|
19 |
SU X, CHENG Y, CHANG D. The important role of leptin in modulating the risk of dermatological diseases[J]. Front Immunol, 2021, 11: 593564.
|
20 |
STJERNHOLM T, OMMEN P, LANGKILDE A, et al. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes[J]. Exp Dermatol, 2017, 26(4): 338-345.
|
21 |
WATANABE Y, YAMAGUCHI Y, TAKAMURA N, et al. Leptin induces interleukin-6 production in keratinocytes via decreased expression of caveolin-1: a possible link between obesity and psoriatic inflammation[J]. Br J Dermatol, 2020, 183(4): 768-770.
|